Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing

Journal of the National Cancer Institute

Volumn 89, Issue 2, 1997, Pages 148-157

  Lerman, Caryn ^a   Biesecker, Barbara ^c   Benkendorf, Judith L ^b   Kerner, Jon ^a   Gomez Caminero, Andres ^a   Hughes, Chanita ^a   Reed, Margaret M ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOTECHNOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; COUNSELING; FEMALE; GENE MUTATION; GENE THERAPY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PATIENT EDUCATION; TUMOR SUPPRESSOR GENE;

EID: 0031030191     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.2.148     Document Type: Article

References (27)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
2. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2 [see comment citation in Medline]. Nature 1995;378:789-92.
3. Nelson NJ. Caution guides genetic testing for hereditary cancer genes [News]. J Natl Cancer Inst 1995;88:70-72.
4. Chaliki H, Loader S, Levenkron JC, Logan-Young W, Hall WJ, Rowley PT. Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health 1995;85(8 Pt 1):1133-5.
5. Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 1995;4:169-73.
6. Lerman C, Daly M, Masny M, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994;12:843-50.
7. Lerman C, Seay J, Balshem A, Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 1995;57: 385-92.
8. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol 1996;14:1730-6; discussion 1737-40.
9. Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship [see comment citations in Medline]. JAMA 1992;267:2221-6.
10. Kessler S. Genetic counseling: psychological dimensions. New York: Academic Press, 1979.
11. Janis IL, Mann L. Decision making: a psychological analysis of conflict, choice, and commitment. New York: The Free Press, 1977.
12. Engel JF, Blackwell RD, Miniard PW. Consumer behavior. 8th ed. Fort Worth (TX): The Dryden Press, 1995.
13. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs (NJ): Prentice-Hall International, 1980.
14. Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 1995;87:286-92.
15. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes [see comment citation in Medline]. JAMA 1996;275:1885-92.
16. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 1995;273:535-41.
17. Sorenson JR, Swazey JP, Scotch NA. Effective genetic counseling: more informed clients. In: Reproductive pasts, reproductive futures-genetic counseling and its effectiveness. New York: Alan R Liss for the March of Dimes Birth Defects Foundation. Birth defects: original article series, 1981;XVII:79-104.
18. Lippman-Hand A, Fraser FC. Genetic counseling: provision and reception of information. Am J Med Genet 1979;3:113-27.
19. Sharpe NF. Informed consent and Huntington disease: a model for communication. Am J Med Genet 1994;50:239-46.
20. Andrykowski MA. Psychosocial factors in bone marrow transplantation: a review and recommendations for research. Bone Marrow Transplant 1994; 13:357-75.
21. Patenaude AF, Rappeport JM, Smith BR. The physician's influence on informed consent for bone marrow transplantation. Theor Med 1986;7:165-79.
22. Leonard CO, Chase GA, Childs B. Genetic counseling: a consumers' view. N Engl J Med 1972;287:443-9.
23. Vlek C. Risk assessment, risk perception and decision making about courses of action involving genetic risk: an overview of concepts and methods. In: Birth defects: original article series, 1987;23:171-207.
24. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system [see comment citation in Medline]. J Natl Cancer Inst 1995;87:1747-59.
25. Powledge TM. Genetic screening as a political and social development. Birth Defects 1974;10:25-55.
26. Hughes C, Gomez-Caminero A, Benkendorf J, Kerner J, Isaacs C, Barter J, et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Education and Counseling. In press.
27. Lubs ML. Does genetic counseling influence risk attitudes and decision making? In: Epstein CJ, Curry CJ, Packman S, Sherman S, Hall BD, editors. Risk, communication, and decision making in genetic counseling. New York: Alan R Liss for The National Foundation-March of Dimes, Birth Defects. Original articles series, 1979;XV:355-67.